CompletedPhase 4NCT02427880
Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema
Studying Non-genetic systemic disease with glomerulopathy as a major feature
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Shiraz University of Medical Sciences
- Principal Investigator
- Mohammad Mahdi Sagheb, MDNephrologist at Shiraz University of Medical Science
- Intervention
- Acetazolamide and Hydrochlorothiazide Followed by Furosemide(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2015
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02427880 on ClinicalTrials.govOther trials for Non-genetic systemic disease with glomerulopathy as a major feature
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07271186Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney DiseaseRegeneron Pharmaceuticals
- RECRUITINGNANCT06622915Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic SyndromeSohag University
- RECRUITINGPHASE3NCT05914155Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic SyndromeShoichi Maruyama MD PhD
See all trials for Non-genetic systemic disease with glomerulopathy as a major feature →